|
Volumn 107, Issue 22, 2003, Pages
|
Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ATORVASTATIN;
CLOPIDOGREL;
DRUG DERIVATIVE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRROLE DERIVATIVE;
TICLOPIDINE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
GRAFT OCCLUSION;
HUMAN;
NOTE;
THROMBOCYTE ACTIVATION;
THROMBOCYTE ADHESIVENESS;
THROMBOCYTE AGGREGATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GRAFT OCCLUSION, VASCULAR;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PLATELET ACTIVATION;
PLATELET ADHESIVENESS;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PYRROLES;
TICLOPIDINE;
MLCS;
MLOWN;
|
EID: 0038718540
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.0000076180.03211.bd Document Type: Note |
Times cited : (7)
|
References (0)
|